 SAN DIEGO, CA ACCESSWIRE May 24, 2021 Obalon Therapeutics, Inc. NASDAQ:OBLN, a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders the Special Meeting on May 25, 2021, at 8:30 a.m. PT. All stockholders are highly encouraged to vote by phone or email on this critical transaction. 